Krocker, Joseph D.
Cotton, Madeline E.
Schriner, Jacob B.
Osborn, Baron K.
Talanker, Michael M.
Wang, Yao-Wei W.
Cox, Charles S. Jr.
Wade, Charles E.
Funding for this research was provided by:
National Institute of General Medical Sciences (T32GM008792)
William Stamps Farish Fund
Howell Family Foundation
James H. "Red" Duke Professorship
Article History
Received: 15 August 2022
Accepted: 3 April 2023
First Online: 10 April 2023
Competing interests
: Dr. Wade holds a financial interest in Decisio Health Inc., is a consultant to CellPhire, and has patents licensed through The University of Texas to Decisio Health and Grifols. Dr. Cox receives support from the following organizations: National Institutes of Health; Department of Defense-Medical Technology Enterprise Consortium; State of Texas Emerging Technology Fund; Generate Life Sciences, Inc.; Athersys, Inc.; Celgene Cellular Therapeutics; Cellvation, Inc.; Cellularity, Inc.; Hope Biosciences, Inc.; The Bentsen Foundation; Mission Connect; Let's Cure CP; Ladybug Foundation; Evelyn Griffin Foundation; Glassell Family Foundation; The George and Cynthia Mitchell Foundation; Grace R. Walls Endowment; Brown Foundation; Cellvation, Inc.; Coagulex, Inc.; EMIT Corporation. These affiliations are unrelated to the present work, and these funders were not involved in the study design, data collection, data analysis, data interpretation, manuscript authorship, or the decision to publish. The other authors report no competing interests.